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Abstract
Background: Cigarette smoking prevalence among gay men is twice that of population levels. A
pilot community-level intervention was developed and evaluated aiming to meet UK Government
cessation and cancer prevention targets.
Methods: Four 7-week withdrawal-oriented treatment groups combined nicotine replacement
therapy with peer support. Self-report and carbon monoxide register data were collected at
baseline and 7 weeks. N = 98 gay men were recruited through community newspapers and
organisations in London UK.
Results: At 7 weeks, n = 44 (76%) were confirmed as quit using standard UK Government
National Health Service monitoring forms. In multivariate analysis the single significant baseline
variable associated with cessation was previous number of attempts at quitting (OR 1.48, p = 0.04).
Conclusions: This tailored community-level intervention successfully recruited a high-prevalence
group, and the outcome data compares very favourably to national monitoring data (which reports
an average of 53% success). Implications for national targeted services are considered.
Background
Analysis of tobacco marketing has demonstrated lesbian
and gay youth as an emerging target community [1],
thereby reinforcing behaviour patterns that contribute to
the adult gay smoking prevalence (39.7–47.8%) being up
to twice that of adult heterosexuals [2].
Gay men have been disproportionately affected by HIV/
AIDS disease in developed countries. HIV risk-taking
behaviour is associated with cigarette smoking among
HIV-negative gay men [3], and among gay men infected
with HIV, studies of co-morbidity and survival have iden-
tified cigarette smoking as a significant risk factor for
opportunistic infections [4] and rapid disease progression
[5]. A review of the evidence on sexuality and cigarette
smoking found the elevated rates of tobacco use to be con-
sistent across international studies, and concluded with a
strengthened call for targeted cessation interventions to
lesbians, gays and bisexuals [6]. None have been pub-
lished to date.
The National Health Service (NHS) Cancer Plan, a UK
Government health strategy, recommends that Primary
Care Trusts (PCTs) take a commissioning lead in forming
local alliances involving community groups, harnessing
community efforts, and dissemination of effective
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interventions. [7]. In order to meet smoking cessation tar-
gets, PCTs are recommended to develop specialist smok-
ing cessation services and develop links with local
community groups [8].
This innovative pilot study aimed to design, recruit to, and
deliver a series of pilot smoking cessation group interven-
tions and to evaluate outcomes using standard UK Gov-
ernment assessment criteria.
Methods
Intervention design
The intervention was developed and delivered by a com-
munity-based volunteer-led charity in London UK, with a
remit to promote the health of gay men. Potential accept-
ability and effectiveness were maximised by providing an
NHS-approved programme adapted for an appropriate
service wholly facilitated and attended by gay men. Seven
volunteers experienced in delivering group interventions
within the organisation were trained in the 3 day course
"Setting up and running specialist Smoking Cessation Clinics",
part of the Smoking Cessation Training and Research Pro-
gramme (SCTRP) at St Bartholomew's and Royal London
School of Medicine and St George's Hospital Medical
School. The programme of withdrawal-oriented treatment
combines groupwork, nicotine replacement therapy
(obtained on prescription from general practitioners) and
ongoing peer support throughout. An initial information
session is followed by 6 closed group sessions, setting a
quit data for week 3. This pilot consisted of 4 delivered
groups, and each group consisted of 7 closed weekly meet-
ings each of 2 hours.
The service principle was for a non-judgemental environ-
ment where gay men could address socialising and gay
social spaces, recreational drug use, sexuality and HIV and
the impact of these on their motivations, and ability, to
quit smoking. Several specific modifications were made to
the taught model. Our intervention modified the SCTRP
program's use of "Quit buddies" which promoted part-
nered support, instead creating "Quit cells" of 3 or 4 par-
ticipants. This design modification was made in the light
of other group interventions delivered by this community
organisation in which reliance of a participant on more
than one person for support has found to be more relia-
ble. The information on Zyban was expanded to address
contraindications with HIV antiretroviral combination
therapies. Exercises from assertiveness training courses
were imported to assist participants in clearly communi-
cating the intention to remain a non-smoker. In general,
group discussion and processes were focussed on cultur-
ally-specific contexts to gay men. A detailed intervention
programme was written in order to promote consistency
across the cycles of intervention delivery.
Week 1: information on the course content as well as
expectations of quit date are given along with information
regarding potential side effects and how to deal with
them. Week 2: what to expect when you quit and how to
deal with reactions, information on the effects of carbon
monoxide, preparation for quit date, personal action plan
and the how to use a smoking diary. Week 3: information
on how to use nicotine replacements, role play of assertive
refusal of cigarettes, selection and formation of quit sup-
port cells, and personal statements of cessation. Week 4:
group review of challenges of the first week of not smok-
ing with reference to smoking diary and personal action
plan, exploration of potential "alternative" support such
as meditation and exercise, discussion of the challenges of
drug use with respect to smoking cessation. Week 5: group
review of previous week's experience, information on
health benefits achieved to date and weight gain issues.
Week 6: review of previous week's experience, identifica-
tion of future sources of support. Week 7: review of previ-
ous week's experience, information of health benefits to
date, elaboration on support sources, small celebration of
the group's achievement.
Recruitment
Twenty-four recruitment advertisements were placed in
free London-wide and national gay press, and accompa-
nying editorial and articles were secured to support the
recruitment process.
Data collection and analysis
Prior to the initial session, participants were sent the
required UK Department of Health self-completion
Smoking Cessation Service NHS Client Assessment Form.
Carbon monoxide readings were taken at each session
from week 2, using the "Smokealyser" calibrated carbon
monoxide register, and readings were used in addition to
self-report data to confirm smoking cessation at week 7.
All intervention attendees were asked to give written per-
mission for data collection purposes and were given guar-
antees of confidentiality.
All data were entered into SPSS for windows V11. In line
with NHS monitoring data requirements, the percentage
of successful quitters was calculated as those who gave car-
bon monoxide readings and confirmed they had quit at
week 7 as a percentage of those who set a quit date for
week 3. Variables were entered individually into univari-
ate binary logistic regressions, with cessation outcome as
the dependent variable and participant baseline character-
istics, attitudes and behaviour, and nicotine replacement
methods as independent variables. Variables with p values
below 0.25 were then entered stepwise into a multivariate
logistic regression, with 95% confidence intervals (95%
CI) reported.BMC Public Health 2004, 4:43 http://www.biomedcentral.com/1471-2458/4/43
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Results
Participant characteristics
Ninety-eight men registered to attend the intervention,
and of these 76 attended at least the first session. Sixty-
nine of men returned the assessment sheet, and the out-
come analysis is of those 69 men.
The mean age of participants was 37.1 years (range 23–63,
SD = 7.2 years), and n = 63 (90%) reported their ethnicity
as White. Forty-four men (64%) had been educated to
degree level or higher, and n = 52 (75%) were in full time
employment with a further 9 (13%) men medically
retired, n = 5 (7%) unemployed, n = 2 (3%) in full time
education and n = 1 (1%) retired. Seventeen men (25%)
were entitled to free prescriptions (i.e. the welfare state
pays for their prescribed medications). Sixty-five men
(94%) reported that they drink alcohol, consuming a
mean of 22.8 units per week (median = 20, SD = 19, range
1–120).
Smoking behaviours at baseline
The daily number of cigarettes smoked was as follows: 1–
5 (n = 3, 4%); 5–10 (n = 5, 7%); 11–20 (n = 27, 39%); 21–
30 (n = 21, 30%); 31–40 (n = 8, 12%); 41+ (n = 5, 7%).
The first cigarette after waking was smoked during the fol-
lowing number of minutes after waking: 5 minutes (n =
19, 28%); 6–30 minutes (n = 31, 45%); 31–60 minutes (n
= 7, 10%); 61+ minutes (n = 11, 16%). Smoking
motivations are summarised in Table 1.
Health status and consultations
Participants reported a mean 2.6 of consultations with
their primary care General Practitioner (GP) in the previ-
ous year (median = 2, SD 3.5). Secondary/hospital con-
sultations in the previous year were reported by n = 35
(52%) men, with a mean of 2.26 consultations for these
men (median = 1, SD = 3.9). Thirty-four men (51%) had
been recommended by their GP to give up cigarette smok-
ing, and n = 26 (38%) men were currently on prescribed
medication. Fourteen men (20%) were diagnosed HIV-
positive, n = 25 (51%) HIV-negative, n = 16 (23%)
untested and n = 4 (6%) refused to answer. The partici-
pants rated their health as follows: excellent n = 10
(14.5%); good n = 36 (52%); moderate n = 20 (29%);
poor n = 2 (3%); very poor n = 1 (1%).
Quitting motivations and history
Sixty-one men (90%) had made a previous attempt to
quit, and of those who had made an attempt the mean
was 2.85 attempts (median 3, SD = 1.4). Previously
employed nicotine replacement methods were gum n =
30 (49%), patches n = 30 (49%), nasal spray n = 3 (5%),
inhalor n = 12 (20%), microtabs n = 3 (5%), nicotine loz-
enges n = 4 (7%), and Bupropion (Zyban) n = 12 (20%).
Participants described the importance of this current
attempt to quit as extremely important (n = 33, 48%);
very important (n = 27, 39%); quite important (n = 9,
13%); not at all important (n = 0). Participants rated their
chances of quitting for good on this attempt as extremely
high (n = 10, 15%); very high (n = 27, 39%); quite high
(n = 24, 35%); not very high (n = 7, 10%); very low (n =
1, 1%).
Intervention attendance and outcomes
Attendance at sessions was consistently high, of 532 per-
son-sessions 13 sessions were missed. Non-attendance
did not apparently cluster around a particular session.
At week 3, of the 69 men who gave data, n = 58 men
(84%) set a quit date. At week 7 (4 weeks after the quit
date) n = 44 men (64%) were confirmed as having quit
using the CO monitor, representing 58% of those who
attended the first session, 76% of those who set a quit date
and 64% of those who gave data at baseline and week 7.
A further 3 men reported by telephone that they had quit
smoking but did not attend the final session to give clini-
cal data to verify. Nine men (13%) reported not having
stopped smoking, n = 6 men (9%) set a quit date at week
3 and did not return to group, n = 7 men (10%) attended
the first session only. For the purposes of this analysis,
these 25 men were coded as not having quit in the follow-
ing modelling.
Table 1: Smoking behaviour at baseline
(Strongly) agree Neither (Strongly) Disagree
I enjoy smoking 44 (64) 11 (16) 13 (18)
Smoking helps me cope with stress 38 (55) 15 (22) 15 (21)
Smoking helps me to socialise 39 (57) 16 (23) 13 (19)
Smoking helps me to cope with boredom 31 (45) 22 (32) 15 (21)
I smoke to keep my weight down 5 (7) 7 (10) 55 (80)BMC Public Health 2004, 4:43 http://www.biomedcentral.com/1471-2458/4/43
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Variables associated with cessation outcomes in 
multivariate logistic regression
This analysis considers those 44 men confirmed as having
ceased compared to those 25 categorised as not having
quit. Following univariate analysis (see Table 2), the 4 var-
iables entered into the multivariate model were smoking
for enjoyment, number of cigarettes per day, smoking to
keep weight down, and number of previous attempts.
Only the latter (continuous) variable was significantly
associated with successful quitting at week 7 (OR = 1.48,
95% CI = 1.02, 2.14, p = 0.04). Data from the multivariate
model are presented in Table 3.
Discussion
This pilot intervention has targeted a hitherto overlooked
high smoking prevalence group, and has adapted a Gov-
ernment-approved intervention to meet the specific needs
of gay men in an appropriate and acceptable setting. The
success rate of 76% of men who had set a quit date being
confirmed as having quit at week 7 compares extremely
favourably to national monitoring data, which reports a
success rate nationally 2001–2002 for smoking cessation
services as 53% [9].
Public health targets must consider the needs of high prev-
alence communities, and this may be achieved through
innovative development of existing effective services.
However, this study has highlighted the lack of targeted
interventions for gay men, and the evidence demonstrates
further elevated health needs compared to the general
population in the fields of alcohol and drug use [10] men-
tal health [11] and cancer [12,13].
Further research may identify the factors which contrib-
uted to the effectiveness of this pilot complex participative
intervention, including offering recruitment and delivery
outside of community settings, measuring success rates
for gay men in non-gay specific or tailored groups, and the
usefulness of "quit cells". Longer-term follow-up data and
increasing dosage to include a follow-up session would
also provide further useful data. In order to refine the
intervention for trial testing, qualitative data regarding the
utility, acceptability and preferences for the content of
specific sessions would be illuminating. Further, the non-
randomised design without comparison group limits
presents a limitation to the generalisability of findings, yet
still offers cessation outcomes much better than standard
national cessation data quoted above which were col-
lected without quasi-experimental design using the same
follow-up period. Data were not available on the 29 men
who registered for the course but did not attend or com-
plete baseline data, and so it is not possible to compare
their demographics or smoking behaviours to those who
took up the intervention. Certainly, replication of this first
pilot would be necessary in other settings, e.g. non-metro-
politan communities, where issues of feasibility and
uptake should be addressed. Commissioners may con-
sider the purchase of existing facilitators from cities to
deliver in non-metropolitan areas where demand is likely
Table 2: Univariate binary regression analysis of demographic and behavioural baseline data with respect to cessation outcomes
Variable p Odds Ratio 95% CI
Age 0.36 1.03 0.96, 1.11
"I enjoy smoking" 0.22* 1.38 0.82, 2.32
"Smoke helps me cope with stress" 0.39 0.82 0.53, 1.29
"Smoking helps me to socialise" 0.58 0.89 0.58, 1.36
"Smoking helps me to cope with boredom" 0.97 0.99 0.63, 1.55
"I Smoke to keep down weight" 0.18* 1.41 0.85, 2.33
No. of cigarettes per day 0.08* 0.67 0.42, 1.05
Time to 1st daily cigarette 0.52 1.18 0.71, 1.96
No. of previous attempts 0.04* 1.44 1.02, 2.01
Importance of this attempt 0.80 0.91 0.45, 1.84
No. of GP visits 0.33 1.09 0.92, 1.29
No. of secondary care visits 0.43 1.06 0.92, 1.22
Expected chance of quitting success on this attempt 0.91 0.97 0.58, 1.62
Perceived health status 0.96 1.02 0.55, 1.90
* Included in multivariate analysis (see Table 3)
Table 3: Multivariate analysis of variables identified as associated 
with cessation at week 7 (i.e. p < 0.25 in univariate analysis, Table 
2).
Variable p Odds Ratio 95% CI
No of cigarettes per day 0.15 0.68 0.41, 1.14
Smoking to keep down weight 0.20 1.43 0.83, 2.45
No of previous attempts to give up 0.04* 1.48 1.02, 2.14
I enjoy smoking 0.38 1.30 0.73, 2.30Publish with BioMed Central    and   every 
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to be lower, as smoking cessation service recommenda-
tions state that group leaders need to keep up to date with
their skills and to use them on a regular basis [14].
Conclusions
In order to meet the smoking cessation needs of this hith-
erto overlooked population, and to meet public health
policy targets, a rigorous research agenda must be estab-
lished. While the use of required standard outcome mon-
itoring must be continued, rigorous experimental trials
using longer term follow up and commonly reported
measures are required. Complex participative interven-
tions must be developed, as in this pilot, from evidence-
based interventions with full programme description to
ensure replication. The development of appropriate inter-
ventions must first pilot services to ensure that they are
appropriately adapted to maximise acceptability and
uptake among target communities.
Lastly, provision of the service by skilled volunteer facili-
tators has ensured an acceptable, low-cost intervention
with a rate of effectiveness in these four pilot groups that
compares favourably to national non-targeted interven-
tions outcomes calculated using standard assessment for-
mula. Acceptability of the model appears high with
respect to the low number of missed sessions. Voluntary
sector provision and delivery should be considered as a
low-cost and highly acceptable point of delivery for effec-
tive community-level smoking cessation interventions.
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